ASBP

Aspire Biopharma Holdings, Inc. Common Stock

57 hedge funds and large institutions have $265M invested in Aspire Biopharma Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
-4
Holders Change %
-6.56%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
10
Reduced
9
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
GCL
1
Glazer Capital LLC
New York
$22.9M +$1.16M +112,312 +5%
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$21.6M
SCM
3
Saba Capital Management
New York
$20.6M +$363K +35,235 +2%
HCM
4
Highbridge Capital Management
New York
$14.4M -$6.87M -665,521 -32%
Millennium Management
5
Millennium Management
New York
$12.1M
HSBC Holdings
6
HSBC Holdings
United Kingdom
$11.9M
SC
7
Sculptor Capital
New York
$11.9M
PC
8
Periscope Capital
Ontario, Canada
$10.7M +$752K +73,000 +8%
AA
9
AQR Arbitrage
Connecticut
$9.14M
KC
10
Kepos Capital
New York
$7.73M +$773K +75,000 +11%
Barclays
11
Barclays
United Kingdom
$7.21M
Verition Fund Management
12
Verition Fund Management
Connecticut
$7.13M -$81.9K -7,952 -1%
FTCM
13
First Trust Capital Management
Illinois
$6.9M
LA
14
Linden Advisors
New York
$6.7M
RCM
15
Radcliffe Capital Management
Pennsylvania
$6.59M +$3.5M +339,853 +113%
Two Sigma Investments
16
Two Sigma Investments
New York
$6.44M
TCA
17
Taconic Capital Advisors
New York
$6.19M
MF
18
Magnetar Financial
Illinois
$5.46M
CF
19
Cantor Fitzgerald
New York
$5.15M
WAM
20
Wolverine Asset Management
Illinois
$5.14M +$898K +87,224 +21%
Goldman Sachs
21
Goldman Sachs
New York
$4.67M
Marshall Wace
22
Marshall Wace
United Kingdom
$4.16M
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$4.15M
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$4.13M
SRCM
25
Sage Rock Capital Management
New York
$3.19M -$486K -47,142 -13%